Pharmaceutical giant in south China in full gear to guarantee COVID drug supply

Production lines of a pharmaceutical enterprise in south China's Guangzhou City have been transformed to produce ibuprofen, a well-needed drug to reduce fever that often come with COVID infection. Daily production can reach three million pills. The enterprise is one of China's largest and produces nearly 60 kinds of medicine that are listed as key drugs for COVID treatment in the province. The production resumption comes under a government project to guarantee a stable medical supply given an upsurge of China's COVID patients.

Search Trends